We are looking for young people aged 2 to 17 years to join a Crohn’s disease (CD) trial to help us discover more about treating moderate to severe CD. If you are looking for a potential new treatment option for moderate to severe CD or moderate to severe IBD (including associated symptoms such as abdominal pain, fatigue, bloody stool, weight loss and/or joint pain), consider one of our GI research studies. All eligible participants will receive no-cost study-related care and study medication. Your young people aged 2 to 17 years may be eligible to take part.
Your child may be eligible to take part in the GI research studies if they:
- are 2‒17 years of age
- have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
- have previously received treatment for UC or CD that has not worked.
Is your child eligible?
